Importantly, Losartan administration did not affect biometric and nutritional performance; comparatively, few studies [9], [40]–[43] have shown the impact of AT1R blockade interventions on biometric profile in rats with diet-induced obesity. This evidence concerns the gene AGTR1 and obesity due to melanocortin 4 receptor deficiency.